Sky9 Capital
  • Home
  • About Us
  • Boundaries
  • Innovators
  • Insights
  • VC 3.0
  • Our Team
  • News
  • LP Login
  • EN
  • 中文
Jing Xiao
Close
Jing Xiao
Vice President

Ms. Jing Xiao focuses on investing in biotech, medical services, and healthcare. The sub-sectors she is interested in include new drug modalities and therapy development, interdisciplinary innovation in biotech applications, and novel platform-based technologies such as synthetic biology. She has over 3 years of healthcare investment experience plus startup experience at a digital healthcare company. Companies she invested in include Trifo, Joint Therapeutics, Rootpath and Revir Therapeutics. She is also responsible for the management of the fund’s healthcare investments.

Previously, she worked at TusStar and Yidu Cloud.

Jing holds a Ph.D. from the School of Medicine and a B.S. from the School of Life Sciences of Tsinghua University.

Favorite Innovator
Come up with new approaches in the way he did not succeed before the others said that he was whimsical.
Mark Twain
info@sky9capital.com
Silicon Valley
200 Kansas St Ste 200, San Francisco
CA 94103
Singapore
350 Orchard Road #11-08, Suite 52, Shaw House
238868
Beijing
Suite 1803 B, Tower F, Phoenix Place A5 Shuguang Xili, Chaoyang District
100028
Shanghai
Suite 1807, Tower 1, Raffles City Changning 1133 Changning Road, Changning District
200051

© 2023 All Rights Reserved

沪ICP备16022446号 沪公网安备 31010502004665号